BAX 📈 Baxter International - Overview

Baxter International Inc. is a global healthcare company that develops and provides a wide range of medical products and services through its subsidiaries. The company's operations are divided into four main segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. This structure allows Baxter to cater to various aspects of healthcare, from medical devices and pharmaceuticals to kidney care and other specialized therapies.

The company's product portfolio is extensive, featuring sterile intravenous solutions, infusion systems, parenteral nutrition therapies, and generic injectable pharmaceuticals. Additionally, Baxter offers surgical hemostat and sealant products, advanced surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. Its surgical equipment includes video technologies, precision positioning devices, and other accessories designed to enhance surgical outcomes. The company also provides administrative sets, adhesion prevention products, inhaled anesthesia, and drug compounding services, further expanding its reach in the healthcare sector.

Baxter's products and services are utilized in a variety of settings, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and even in patients' homes under the supervision of healthcare professionals. The company's global presence is significant, with sales operations in approximately 100 countries, facilitated through a combination of direct sales forces and independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. This extensive distribution network ensures that Baxter's products are accessible to a broad audience worldwide.

The company is also engaged in collaborative efforts to advance healthcare technologies and treatments. For instance, it has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products. Furthermore, Baxter has a collaborative research agreement with Miromatrix Medical Inc. aimed at improving care for patients with acute liver failure. These partnerships underscore the company's commitment to innovation and its role in the global healthcare community. With a history dating back to 1931, Baxter International Inc. is headquartered in Deerfield, Illinois, and its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol BAX.